Literature DB >> 23138653

The role of C-terminal binding protein 2 in Schwann cell differentiation after sciatic nerve crush.

Xingjian Cao1, Ping Zhao, Guohua Tao, Yihua Zhu, Feng Zhou, Zhiming Cui, Guofeng Bao, Dawei Xu, Guowei Zhang, Xiang Chen.   

Abstract

C-terminal binding protein 2 (CtBP2), as a transcriptional repressor, plays an essential role in development and tumorigenesis. However, its distribution and function in peripheral system lesion and repair are still unknown. Here, we investigated the spatiotemporal expression of CtBP2 in rat sciatic nerve crush model. Western blot analysis revealed that CtBP2 was expressed in normal sciatic nerve. It gradually decreased, reached minimal levels at 7 days after crush, and then returned to the normal level at 4 weeks. We observed that CtBP2 is mainly expressed in Schwann cells (SCs). In vitro, we induced SC differentiation via cyclic adenosine monophosphate (cAMP) and found that CtBP2 expression was downregulated during the process of differentiation. CtBP2-specific siRNA inhibited the cAMP-induced expression of the immature SC marker P75(NTR), and exogenous CtBP2 expression upregulated the expression of P75(NTR). Taken together, we hypothesized that peripheral nerve crush-induced downregulation of CtBP2 in the sciatic nerve was associated with SC differentiation, and CtBP2 likely played an important role in peripheral nerve injury and regeneration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23138653     DOI: 10.1007/s12031-012-9916-0

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  29 in total

Review 1.  Molecular mechanisms of cellular interactions in peripheral nerve regeneration.

Authors:  P Küry; G Stoll; H W Müller
Journal:  Curr Opin Neurol       Date:  2001-10       Impact factor: 5.710

2.  The neurotrophin receptor p75NTR as a positive modulator of myelination.

Authors:  Jose M Cosgaya; Jonah R Chan; Eric M Shooter
Journal:  Science       Date:  2002-11-08       Impact factor: 47.728

3.  Involvement of CtBP2 in LPS-induced microglial activation.

Authors:  Guowei Zhang; Yaohua Yan; Lihua Kang; Qi Cao; Kaifu Ke; Xinmin Wu; Yilu Gao; Qinglei Hang; Chunmiao Li; Lin Zhu; Qin Yuan; Qiyun Wu; Chun Cheng
Journal:  J Mol Histol       Date:  2012-03-17       Impact factor: 2.611

4.  CtBP2 downregulation during neural crest specification induces expression of Mitf and REST, resulting in melanocyte differentiation and sympathoadrenal lineage suppression.

Authors:  Hongzi Liang; Donna M Fekete; Ourania M Andrisani
Journal:  Mol Cell Biol       Date:  2011-01-03       Impact factor: 4.272

Review 5.  Degeneration and regeneration of the peripheral nervous system: from Augustus Waller's observations to neuroinflammation.

Authors:  Guido Stoll; Sebastian Jander; Robert R Myers
Journal:  J Peripher Nerv Syst       Date:  2002-03       Impact factor: 3.494

6.  The POU factor Oct-6 and Schwann cell differentiation.

Authors:  M Jaegle; W Mandemakers; L Broos; R Zwart; A Karis; P Visser; F Grosveld; D Meijer
Journal:  Science       Date:  1996-07-26       Impact factor: 47.728

7.  Hdm2 recruits a hypoxia-sensitive corepressor to negatively regulate p53-dependent transcription.

Authors:  Alexander H Mirnezami; Sandra J Campbell; Matthew Darley; John N Primrose; Peter W M Johnson; Jeremy P Blaydes
Journal:  Curr Biol       Date:  2003-07-15       Impact factor: 10.834

8.  The alternative reading frame tumor suppressor antagonizes hypoxia-induced cancer cell migration via interaction with the COOH-terminal binding protein corepressor.

Authors:  Seema Paliwal; Ramesh C Kovi; Bharath Nath; Ya-Wen Chen; Brian C Lewis; Steven R Grossman
Journal:  Cancer Res       Date:  2007-10-01       Impact factor: 12.701

Review 9.  The transcriptional corepressor CtBP: a foe of multiple tumor suppressors.

Authors:  G Chinnadurai
Journal:  Cancer Res       Date:  2009-01-20       Impact factor: 12.701

10.  Krox-20 controls myelination in the peripheral nervous system.

Authors:  P Topilko; S Schneider-Maunoury; G Levi; A Baron-Van Evercooren; A B Chennoufi; T Seitanidou; C Babinet; P Charnay
Journal:  Nature       Date:  1994-10-27       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.